Disease Information & Support

www.lls.org/diseaseinformation

The Word:

donate

Generic name Nelarabine
Pronunciation Nel-AY-re-been
Brand name(s), other common name(s) Arranon®
Drug type  Antimetabolite
How the drug is given Intravenously (IV)

Nelarabine is FDA approved to treat people who have relapsed or refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma following treatment with at least two chemotherapy regimens.

Side effects needing medical attention: Seizures; excessive sleepiness; numbness and tingling in the hands, fingers, feet or toes; problems with fine motor skills such as buttoning clothes; unsteadiness while walking; increased tripping while walking; weakness when getting out of a chair or walking up stairs; fever; signs of infection; bruising easily or unusual bleeding; difficulty breathing; fatigue; paleness.

 

For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012